Edwards Lifesciences Corp (NYSE: EW) on Tuesday, plunged -0.41% from the previous trading day, before settling in for the closing price of $70.63. Within the past 52 weeks, EW’s price has moved between $58.93 and $96.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 4.94% annually for the last half of the decade. The company achieved an average annual earnings per share of 0.96%. With a float of $576.41 million, this company’s outstanding shares have now reached $588.60 million.
In an organization with 15800 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 78.39%, operating margin of 26.37%, and the pretax margin is 27.76%.
Edwards Lifesciences Corp (EW) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Edwards Lifesciences Corp is 1.95%, while institutional ownership is 87.14%. The most recent insider transaction that took place on Mar 13 ’25, was worth 645,624. In this transaction CVP,Strategy/Corp Development of this company sold 9,500 shares at a rate of $67.96, taking the stock ownership to the 46,936 shares. Before that another transaction happened on Mar 10 ’25, when Company’s CEO sold 6,164 for $69.51, making the entire transaction worth $428,448. This insider now owns 59,083 shares in total.
Edwards Lifesciences Corp (EW) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.32% during the next five years compared to 7.29% growth over the previous five years of trading.
Edwards Lifesciences Corp (NYSE: EW) Trading Performance Indicators
Edwards Lifesciences Corp (EW) is currently performing well based on its current performance indicators. A quick ratio of 3.45 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.22. Likewise, its price to free cash flow for the trailing twelve months is 142.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.38, a number that is poised to hit 0.60 in the next quarter and is forecasted to reach 2.75 in one year’s time.
Technical Analysis of Edwards Lifesciences Corp (EW)
Let’s dig in a bit further. During the last 5-days, its volume was 4.79 million. That was better than the volume of 4.53 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 47.37%. Additionally, its Average True Range was 1.77.
During the past 100 days, Edwards Lifesciences Corp’s (EW) raw stochastic average was set at 46.03%, which indicates a significant decrease from 51.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.65% in the past 14 days, which was lower than the 25.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $71.63, while its 200-day Moving Average is $73.23. However, in the short run, Edwards Lifesciences Corp’s stock first resistance to watch stands at $70.94. Second resistance stands at $71.53. The third major resistance level sits at $71.99. If the price goes on to break the first support level at $69.88, it is likely to go to the next support level at $69.42. Assuming the price breaks the second support level, the third support level stands at $68.83.
Edwards Lifesciences Corp (NYSE: EW) Key Stats
Market capitalization of the company is 41.35 billion based on 587,900K outstanding shares. Right now, sales total 5,440 M and income totals 4,175 M. The company made 1,101 M in profit during its latest quarter, and 385,600 K in sales during its previous quarter.
